Tech Company Financing Transactions

Metacrine Funding Round

Metacrine, based in San Diego, secured $65 million in funding from Venrock, Alexandria Venture Investments and Arch Venture Partners.

Transaction Overview

Company Name
Announced On
6/8/2018
Transaction Type
Venture Equity
Amount
$65,000,000
Round
Series C
Proceeds Purpose
Metacrine plans to use proceeds from the Series C financing to advance its clinical development pipeline, including its lead candidate MET409 for the potential treatment of NASH, IBS-D, and inflammatory bowel disease, and to expand its pipeline through continued internal discovery efforts. A Phase 1 clinical study of MET409 is planned to begin later this month.

Company Information

Company Status
Publicly-held
Industry
Biopharmaceutical
Mailing Address
3985 Sorrento Valley Blvd. C
San Diego, CA 92121
USA
Email Address
Overview
Metacrine (Nasdaq: MTCR) is a biotech company founded in 2015 on technology licensed from the laboratory of Dr. Ronald Evans, a world leader in nuclear hormone receptors and Howard Hughes Medical Institute Investigator at the Salk Institute.
Profile
Metacrine LinkedIn Company Profile
Social Media
Metacrine Company Twitter Account
Company News
Metacrine News
Facebook
Metacrine on Facebook
YouTube
Metacrine on YouTube

Management Team

Title
Name
Email & Social
Chief Executive Officer
Preston Klassen
  Preston Klassen LinkedIn Profile  Preston Klassen Twitter Account  Preston Klassen News  Preston Klassen on Facebook
Chief Financial Officer
Trisha Millican
  Trisha Millican LinkedIn Profile  Trisha Millican Twitter Account  Trisha Millican News  Trisha Millican on Facebook
Vice President
Nicholas Smith
  Nicholas Smith LinkedIn Profile  Nicholas Smith Twitter Account  Nicholas Smith News  Nicholas Smith on Facebook
VP - Operations
Eric Bischoff
  Eric Bischoff LinkedIn Profile  Eric Bischoff Twitter Account  Eric Bischoff News  Eric Bischoff on Facebook


 

 

Browse more venture capital transactions:

Prev: 6/8/2018: Zebra Medical Vision venture capital transaction
Next: 6/8/2018: Devo venture capital transaction

 

Share this article

 


Where The Data Comes From

We do our best to document every notable VC transaction. VC investment data records reported here are sourced from company press releases and news coverage. The information comes to us via our partnership with VentureDeal.com, an affiliated venture.

 


Additional Resources for Entrepreneurs

Lists of Venture Capital and Private Equity Firms

Franchise Opportunities

Contributors

Business Glossary